Table 3.
Relative expression of genes | |||||||
---|---|---|---|---|---|---|---|
CD | HD | B1D | B2D | B3D | B4D | B5D | |
tnfα | 1.00 ± 0.049b | 1.86 ± 0.096d | 1.48 ± 0.074c | 1.76 ± 0.018d | 0.63 ± 0.029a | 0.44 ± 0.031a | 1.87 ± 0.171d |
il1β | 1.01 ± 0.080a | 2.05 ± 0.213b | 1.77 ± 0.102b | 1.79 ± 0.079b | 1.25 ± 0.041a | 1.71 ± 0.118b | 1.74 ± 0.136b |
il10 | 1.00 ± 0.065d | 0.33 ± 0.008a | 0.54 ± 0.047b | 0.52 ± 0.026b | 1.46 ± 0.032e | 0.85 ± 0.044c | 0.45 ± 0.039ab |
cxcl8 | 1.00 ± 0.044a | 2.89 ± 0.11c | 2.34 ± 0.255b | 1.34 ± 0.051a | 1.19 ± 0.101a | 2.57 ± 0.057bc | 2.87 ± 0.175c |
tnfα, tumor necrosis factor-alpha; il1β, interleukin 1β; cxcl8, CXC chemokine ligand 8. Data are normalized to 18s (18S ribosomal RNA) and β-actin as the reference genes and presented as a fold change in relation to the control group (CD, set as 1) (n = 6). Values are presented as means with SD, where significant (p < 0.05) differences between groups are indicated by different letters.